Focus | Pipeline

We are leveraging our proprietary platform to develop redosable gene therapies to treat serious rare diseases caused by the absence of, or a mutation in, a single gene. In addition to this work, we are currently researching the potential of our platform to address more prevalent, chronic conditions.